Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. Baldanti, F. Bini, V. Conio, V. Rognoni, A. Cascina, C. Lastoria, T. Oggionni, F. Meloni (Pavia, Italy). The role of EBV DNAemia in the assessment of post-transplant lymphoproliferative disorders (PTLD). Eur Respir J 2009; 34: Suppl. 53, 2242

Member's Comments

No comment yet.

Related content which might interest you: Could LDH monitoring after lung transplantation be used as screening tool for post-transplant lymphoproliferative disorder (PTLD)? Source: International Congress 2017 – Lung transplant outcomes Year: 2017 Post-transplant lymphoproliferative disease and other malignancies Source: Eur Respir Mon; 2009: 45: 226–237 Year: 2009 Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 Pulmonary viral infection in hematologic patients with and without stemcell transplantation Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Lymphoproliferative disease and other malignancies Source: ERS Course 2016 Year: 2016 Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 EBV and CMV as possible pathogens in patients presenting with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection? Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 The role of cytomegalovirus infection in the course of the lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Clonality analysis in lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung Source: Eur Respir J 2006; 28: Suppl. 50, 306s Year: 2006 High levels of Epstein-Barr virus in COPD Source: Eur Respir J 2008; 31: 1221-1226 Year: 2008 Medical complications of lung transplantation Source: Eur Respir J 2004; 23: 334-342 Year: 2004 Hypo gammaglobulinemia (gG) after lung transplantation: impact of non specific gG replacement on infection and rejection Source: Eur Respir J 2003; 22: Suppl. 45, 202s Year: 2003 Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 Early recurrence of pneumocystis jiroveci pneumonia (PCP) in two HIV-infected patients: linking infection relapse and immune reconstitution syndrome Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012